Skip to main content
IJID Regions logoLink to IJID Regions
. 2026 Sep 3;21:101000. doi: 10.1016/j.ijregi.2026.101000

The prevalence of latent tuberculosis infection among healthcare workers in Saudi Arabia: a systematic review and meta-analysis

Mohammed Aljabr 1, Fatima N Boumarah 2, Yara Mortada 3, Ghala Alhmidani 4, Rakan Almutairi 5, Jory Msood 6, Noor Alfaraj 7, Shatha Abohimed 8, Adel Almaghrbi 9, Reham Algethami 10, Refal Alsaedi 3, Sadeem Al Maqeet 11, Abdullah Aljorayid 12,⁎
PMCID: PMC13627945  PMID: 42824734

Highlights

  • •

    This is the first meta-analysis of latent tuberculosis in Saudi healthcare workers.

  • •

    Pooled latent tuberculosis prevalence among healthcare workers was 24%

  • •

    Expatriate workers from endemic countries had triple the prevalence of nationals.

  • •

    Test discordance suggests skin testing may overestimate in bacille Calmette-Guérin-vaccinated groups.

  • •

    Findings support transitioning to blood-based screening for this population.

Keywords: Latent tuberculosis infection, Healthcare workers, Prevalence, Saudi Arabia, Occupational exposure

Abstract

Objectives

This systematic review and meta-analysis aimed to estimate the prevalence of latent tuberculosis infection (LTBI) among healthcare workers (HCWs) in Saudi Arabia and identify key associated risk factors.

Methods

A systematic search of PubMed, Web of Science, and MEDLINE and Embase (via Ovid) was conducted for studies reporting LTBI prevalence among HCWs in Saudi Arabia. Data were pooled using a random-effects model. Subgroup analyses assessed variations by diagnostic method, professional category, and nationality.

Results

The overall pooled prevalence was 24% (95% confidence interval [CI] = 16-34%), with high heterogeneity across studies (I² = 98.8%). Prevalence was numerically higher in tuberculin skin test (TST)-based studies (27%) than in interferon-gamma release assay (IGRA)-based studies (20%), although this difference did not reach statistical significance (P = 0.13). TST-positive/IGRA-negative discordance was the predominant pattern. Expatriate HCWs from high-burden countries showed prevalence rates of 45-46%, compared to 13% among Saudi nationals. Allied health professionals and nurses exhibited higher prevalence trends, though these did not reach statistical significance.

Conclusion

The LTBI burden among HCWs in Saudi Arabia is substantial and largely imported by expatriate workers from high-burden countries, with a possible secondary occupational contribution. TST–IGRA discordance suggests that TST may overestimate prevalence in this bacille Calmette-Guérin-vaccinated population. Based on discordance patterns and supporting evidence, transitioning to IGRA-based screening and implementing targeted surveillance for high-risk groups should be considered.

Introduction

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a global health challenge. Although it is a preventable and generally curable disease, it persists as the leading cause of death from a single infectious agent. The World Health Organization reported 10.8 million new cases and 1.25 million deaths that occurred worldwide during 2023 [1]. The disease burden exists mainly in low- and middle-income countries, most likely because of the socioeconomic constraints and limited healthcare access, which enable the disease to continue spreading [2].

The reservoir of latent tuberculosis infection (LTBI) is a key part of the TB epidemic. The immune system activates against M. tuberculosis antigens during LTBI, but the body does not display any symptoms of active TB [3]. People with LTBI are not contagious, but they remain at risk for disease reactivation, which is estimated at between 5% and 10%, with the highest risk in the first 2 years after infection [1,[3], [4], [5]]. Research shows that LTBI exists in 25% of the human population worldwide [6]. With the reactivation risk, this will continue to cause new active cases, which will prevent the world from reaching its TB elimination goals [1,7].

Healthcare workers (HCWs) are at risk for both LTBI and active TB disease. This risk is driven by the frequency and duration of exposure to infectious patients, the handling of contaminated specimens, and the effectiveness of infection control measures [8,9]. Compared with the general population, HCWs face a twofold increased risk of LTBI and a threefold increased risk of active TB, as shown in a recent systematic review by Uden et al., [10]. Additionally, this occupational risk persists even for HCWs practicing in countries with low TB incidence [11].

Saudi Arabia faces a unique epidemiological situation in regard to TB control. While it is considered a low-burden country with an incidence of 8.4 per 100,000 population [12], the kingdom has a big expatriate workforce originating largely from high-TB-burden regions [13]. Additionally, the annual Hajj and Umrah pilgrimages bring millions of people in close proximity, which makes it easier for airborne diseases to spread [[13], [14], [15]]. This dynamic environment exposes HCWs to a global TB risk profile despite the low local incidence.

The assessment of LTBI prevalence among HCWs in Saudi Arabia is important given these unique demographic and religious factors. This will impact workplace safety and infection control guidance. To our knowledge, no systematic review reports the data on this specific population. This study aimed to systematically review the literature and estimate the pooled prevalence of LTBI among HCWs in Saudi Arabia and identify associated risk factors, with the goal of informing future occupational health strategies.

Methods

Study design and protocol

The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [16]. The study protocol was prospectively registered with PROSPERO (Registration No. CRD420251077993). As this study combined previously published aggregate data, institutional review board approval was not required.

Search strategy

A comprehensive literature search was executed in December 2025 across the following electronic databases: PubMed, Web of Science, and MEDLINE and Embase (via Ovid). The authors conducted manual screening of reference lists from included articles and relevant reviews to ensure comprehensive coverage. The research question received its structure from the Condition, Context, and Population (CoCoPop) framework [17], which helps develop a focused and rigorous search strategy for prevalence studies. The research focused on LTBI, which affects healthcare facilities throughout Saudi Arabia, focusing on HCWs, including all clinical and nonclinical staff exposed to the hospital environment.

The search strategy used the following keywords and Medical Subject Headings (MeSH) terms: (Latent tuberculosis OR LTBI), (healthcare workers OR occupational exposure), (Tuberculin skin test), and (Prevalence OR Risk factors). Additionally, the search included the following combination: ("epidemiology" OR "prevalence" OR "incidence") AND ("tuberculosis" OR "TB" OR "Mycobacterium tuberculosis" OR "M. tuberculosis") AND ("Saudi Arabia" OR "Saudi" OR "KSA" OR "Kingdom of Saudi Arabia"). In addition, Google Scholar was used as a supplementary source to identify additional relevant studies through citation tracking and gray literature; it was not treated as a primary database due to its limited reproducibility and inability to execute complex Boolean search strings.

Eligibility criteria

Studies were selected based on the following inclusion criteria: (1) published in English; (2) conducted in Saudi Arabia; (3) study population consisting of HCWs; (4) diagnosis of LTBI confirmed via tuberculin skin test (TST) or interferon-gamma release assays (IGRAs); (5) reported prevalence data or sufficient raw data to calculate it; and (6) used an observational study design.

Exclusion criteria were: (1) studies conducted outside Saudi Arabia; (2) case reports, reviews, editorials, and conference abstracts without full text; (3) studies focusing solely on active TB; (4) studies where HCW data could not be disaggregated from patient or general population data; and (5) duplicate publications.

Study selection and data extraction

Two independent reviewers screened titles and abstracts using the Rayyan intelligent systematic review tool [18]. Potentially relevant articles underwent full-text review. Disagreements regarding eligibility were resolved through consensus or consultation with a third senior reviewer.

Data were extracted into a pre-piloted standardized form containing: study characteristics (author, year, region, facility type), participant demographics (sample size, age, sex, nationality, job category), diagnostic methodology (TST cutoff, specific IGRA used), and outcomes (prevalence of LTBI, risk factors).

Quality assessment

The methodological quality of included cross-sectional studies was evaluated using the Appraisal tool for Cross-Sectional Studies (AXIS) [19]. This tool evaluates study design, sampling strategy, measurement validity, statistical analysis, and reporting clarity. Two reviewers independently scored each study, resolving discrepancies through discussion.

Meta-analysis

A meta-analysis of proportions was conducted to estimate the pooled prevalence of LTBI using a random-effects model to account for heterogeneity [20]. The logit transformation method was used to stabilize variances, and heterogeneity was assessed using Cochran Q test, τ², and I² statistics (with I² >75% indicating substantial heterogeneity) [21].

Additionally, we conducted a subgroup analysis based on diagnostic tests (TST vs IGRA) and professional groups. Results were presented in multiple forest plots. Subgroup differences were tested using the chi-square test for heterogeneity. We conducted a sensitivity analysis using a leave-one-out method which involved removing one study at a time to determine how each study affected the combined results. The study evaluated publication bias through contour-enhanced funnel plots together with statistical methods which checked for asymmetry in the data. Given the observational nature of included studies, funnel plot findings were interpreted cautiously.

All analyses were conducted in R software (R Foundation for Statistical Computing, Vienna, Austria) using the meta package [22]. The significance level was set at a two-sided P-value of <0.05.

Results

Study selection

The initial database search yielded a total of 1559 records: 613 from PubMed, 786 from Web of Science, and 160 from Ovid. No additional records were identified through supplementary Google Scholar citation tracking (Figure 1). After removing duplicates, 903 unique records remained for screening. A thorough review of titles and abstracts resulted in the exclusion of 888 records that did not meet the eligibility criteria. Subsequently, the full texts of the remaining 15 articles were assessed for eligibility. Five articles were excluded, leaving 10 studies that met all inclusion criteria. These 10 studies were included in the systematic review and meta-analysis [[23], [24], [25], [26], [27], [28], [29], [30], [31], [32]].

Figure 1.

Figure 1 dummy alt text

PRISMA flow diagram of study selection process.

Abbreviations: HCWs, healthcare workers; IGRA, interferon-gamma release assay; LTBI, latent tuberculosis infection; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; TB, tuberculosis; TST, tuberculin skin test.

Characteristics of included studies

The 10 included cross-sectional studies were conducted in Saudi Arabia between 2003 and 2024, with sample sizes ranging from 134-3024 participants. Participant ages ranged from 18-60+ years, and the proportion of female participants varied between 33% and 88%.

Nurses were the most frequently represented profession, followed by physicians, allied health staff, laboratory technicians, and nonclinical employees. Some studies also included pharmacists, housekeepers, radiology technicians, and medical students. The participants were of diverse nationalities, with expatriates from high-TB-endemic regions, such as the Philippines and India, often outnumbering Saudi nationals. The studies were conducted in tertiary and secondary care hospitals, as well as general hospitals, reflecting a range of healthcare environments. The different studies reported LTBI prevalence rates which spanned from 8.5%-78.9%. A detailed summary of the characteristics of each study is presented in Table 1.

Table 1.

Overview of selected studies on LTBI among HCWs.

Study Study Setting Participants Age Range (years) Sex Distribution Nationality Job Title/ Department Diagnostic Method Prevelance
Koshak and Tawfeeq, 2003 [23] Tertiary Academic Hospital 298 21-59 Male: 58 Female: 240 Saudi Arabia: 40
Philippine: 150
India: 36
Pakistan: 31
Nigeria: 24
Other: 17
Laboratories: 60
Neonatal intensive care unit: 26
Paediatric medical ward: 24
Other Departments: 188
TST 235 (78.9%)
Abbas et al., 2010 [24] Four Tertiary Hospitals 2650 10-50+ Male: 1180
Female: 1470
Saudi Arabia: 1254
Middle East: 285
East Asia: 981
Sub-Saharan: 36
Western: 91
Nurse: 1164
Physician: 429
Technician: 423
Medical student: 181
Administrative employee: 453
TST 291 (11%)
Hassan and Diab, 2014 [25] University Hospital 134 21-60 Male: 72
Female: 62
Saudi Arabia: 97
Middle East: 3
East Asia: 34
Laboratory: 134 IGRA 26 (19.4%)
El-Helaly et al., 2014 [26] Tertiary Care Hospital 1412 19-60 Male: 433
Female: 939
Saudi Arabia: 563
Asia: 686
Africa: 53
Europe: 70
North America: 30
Australia: 10
Nurse: 547
Physician: 197
Other clinical employee: 330
Non clinical employee: 338
TST and IGRA TST: 421 (29.8%)
IGRA: 333 (23.6%)
Hibah and Hasan, 2015 [27] General Hospital 208 20-50+ Male: 91
Female: 117
Saudi Arabia: 24
Middle East: 42
Yemen: 18
Philippine: 83
South Asia: 41
Nurse: 73
Physician: 36
Technician: 29
Administrative employee: 39
Others: 31
TST 47 (22.5%)
Alhajoj et al., 2016 [28] Tertiary Care Hospital 1595 19-60+ Male: 512
Female: 1083
Saudi Arabia: 271
Western-Pacific: 694
Eastern Mediterranean: 303
South East Asian: 150
Others: 177
Nurse: 849
Physician: 44
Allied Health: 248
Supportive Services: 348
Administration: 62
Researchers: 44
TST and IGRA TST: 503 (31.5%)
IGRA: 399 (25%)
Bukhary et al., 2018 [29] Multiple Secondary Care Hospitals 520 22-62 Male: 348
Female: 172
Saudi Arabia: 221
Non-Saudi: 299
Nurse: 160
Physician: 100
Pharmacist: 70
Laboratory Technician: 50
Radiology Technicians: 70
Housekeeper: 70
TST and IGRA TST: 44 (8.5%)
IGRA: 56 (10.8%)
Almohaya et al., 2020 [30] Tertiary Academic Hospital 3024 20-50+ Male: 875
Female: 2149
Saudi Arabia: 750
Philippine: 1341
India: 722
Other: 211
Nurse: 1745
Physician: 123
Allied Health: 318
Laboratory Technician: 49
Radiology Technicians: 43
Non clinical employee: 746
IGRA 733 (24.2%)
Alshahrani et al., 2023 [31] General Hospital 561 23-71 Male: 150
Female: 411
Saudi Arabia: 51
Non-Saudi: 510
Nurse: 367
Physician: 165
Others: 29
TST 66 (11.8%)
Aldhawyan et al., 2024 [32] Tertiary Care Hospital 771 18-59 Male: 92
Female: 679
Saudi Arabia: 99
Philippine: 511
Indian: 88
Other: 73
Nurse: 771 TST 266 (34.5%)

Abbreviations: HCWs, healthcare workers; IGRA, interferon-gamma release assay; LTBI, latent tuberculosis infection; TST, tuberculin skin test.

Diagnostic methods and discordance

Five studies used TST alone, two used IGRA alone, and three utilized both methods. Among the three studies that employed both diagnostic methods, concordant and discordant results were reported.

Across all three studies, concordance between TST and IGRA results varied. El-Helaly et al., reported an overall agreement of 73.7% of results, with most concordance coming from negative results (60.1%) [26]. Similarly, Al Hajoj et al., found 57.7% negative concordance and 14.23% positive concordance [28]. In comparison, Bukhary et al., observed 89.5% negative concordance and 13.6% positive concordance [29].

Discordance between diagnostic methods was a prominent finding in all three studies. The most frequent pattern was TST-positive/IGRA-negative discordance. Among participants who tested positive by TST, a subsequent negative IGRA result was found in 16.3% of the cohort in El-Helaly et al., 54.8% in Al Hajoj et al., and 86.4% in Bukhary et al. Conversely, the TST-negative/IGRA-positive pattern was less common, occurring in 10.1% of participants in El-Helaly et al., 15.7% in Al Hajoj et al., and 10.5% in Bukhary et al., [26,28,29]

Prevalence of LTBI

The overall pooled prevalence of LTBI across the 10 studies was 24% (95% confidence interval [CI] = 16-34%), calculated using a random-effects model (Figure 2). However, there was a large degree of heterogeneity (I² = 98.8%; τ² = 0.0406; P <0.0001) among the included studies.

Figure 2.

Figure 2 dummy alt text

Overall pooled prevalence of LTBI among HCWs.

Abbreviations: CI, confidence interval; HCWs, healthcare workers; IGRA, interferon-gamma release assay; LTBI, latent tuberculosis infection; TST, tuberculin skin test.

The subgroup analysis by diagnostic test is shown in Figure 3. The TST-based studies found a pooled prevalence of LTBI of 27% (95% CI = 13-44%), showing high heterogeneity (I² = 99.3%, τ² = 0.0640, P <0.0001). On the other hand, the IGRA-based studies yielded a pooled prevalence of LTBI of 20% (95% CI = 15-26%), again showing high levels of heterogeneity (I² = 93.7%, τ² = 0.0058, P <0.0001). No statistically significant difference was found between the prevalence estimates calculated using TST and IGRA (χ² = 2.33, degrees of freedom (df) = 1, P = 0.13). The total prevalence estimate pooling the two tests remains at 24% (95% CI = 16-34%).

Figure 3.

Figure 3 dummy alt text

Pooled prevalence of LTBI stratified by diagnostic method.

Abbreviations: CI, confidence interval; IGRA, interferon-gamma release assay; LTBI, latent tuberculosis infection; TST, tuberculin skin test.

The prevalence of LTBI varied across healthcare professional categories (Figure 4). Among nurses, the prevalence was 21% (95% CI = 14-29%), with significant heterogeneity (I² = 97.4%, τ² = 0.0176, P <0.0001). Physicians had a prevalence of 18% (95% CI = 15-22%), with moderate heterogeneity (I² = 33.5%, τ² = 0.0015, P = 0.17). Allied health professionals showed a prevalence of 24% (95% CI = 16-33%), while pharmacists had a prevalence of 6% (95% CI = 2-14%). Medical students had the smallest LTBI prevalence of 2% (95% CI = 1-6%). Among nonclinical employees, the prevalence was 13% (95% CI = 11-16%). The differences between professional categories were not statistically significant (χ² = 2.33, df = 2, P = 0.31).

Figure 4.

Figure 4: dummy alt text

Pooled prevalence of LTBI stratified by professional category.

Abbreviations: CI, confidence interval; IGRA, interferon-gamma release assay; LTBI, latent tuberculosis infection; TST, tuberculin skin test.

The analysis of LTBI prevalence stratified by nationality revealed significant variations. Among Saudi HCWs, the prevalence was 13% (95% CI = 4-24%), with significant heterogeneity (I² = 94.4%). In comparison, non-Saudi HCWs from endemic countries demonstrated substantially higher prevalence rates. For instance, Indian HCWs had a pooled prevalence of 45% (95% CI = 18-73%), while those from the Philippines had a prevalence of 46% (95% CI = 21-72%), both characterized by high heterogeneity (I² > 93%) (Figure S1).

Assessment of publication bias

A visual inspection of the funnel plot showed asymmetry (Figure 5). The high level of heterogeneity in our research results together with the observational design of prevalence studies makes it more likely that the asymmetry revealed in the funnel plot could be due to inter-study variability rather than publication bias.

Figure 5.

Figure 5 dummy alt text

Funnel plot for assessment of publication bias.

Sensitivity analysis

A leave-one-out sensitivity analysis showed that the pooled prevalence remained stable between 23% and 25%, even when individual studies were excluded. Heterogeneity remained high across all iterations (I² ≈ 98-99%), indicating that no single study significantly influenced the overall prevalence estimate (Figure S2).

Quality assessment and risk of bias

The methodological quality of the included studies was assessed using the AXIS appraisal tool, with scores ranging from 15-17 out of a possible 20. Two studies, Alshahrani et al., and Almohaya et al., received the highest score of 17, reflecting strong methodological quality and a lower risk of bias. In contrast, two studies, Abbas et al., and Al Hajoj et al., scored 15, indicating a moderate risk of bias. A common limitation identified across all studies was the lack of justification for sample sizes (Q7 on the AXIS tool), where all 10 studies scored "No." Despite these limitations, the overall quality of the studies was deemed moderate to high, allowing for confident interpretation of the results, while acknowledging potential biases related to these limitations.

Discussion

This review provides the first comprehensive assessment of LTBI prevalence among HCWs in Saudi Arabia. The analysis found a pooled LTBI prevalence of 24% (95% CI = 16-34%), which is suggestive of an elevated occupational risk among HCWs. However, this estimate should be interpreted with caution given the extremely high statistical heterogeneity (I² = 98.8%), the wide range of primary prevalence rates (8.5-78.9%), and the fact that none of the included studies provided adequate sample size justifications. Accordingly, this pooled figure should be viewed as an approximate summary measure indicating a substantial LTBI burden rather than a precise point estimate. Expatriate HCWs from high-TB-endemic countries were found to have prevalence rates nearly triple those of Saudi nationals, suggesting that the Saudi healthcare sector LTBI burden depends mainly on the composition of its workforce.

The study revealed numerically different levels of LTBI prevalence based on the diagnostic method used. The prevalence rate using TST was 27% compared to 20% using IGRAs, although this difference was not statistically significant (P = 0.13). Similarly, the professional categories showed no statistically significant difference (P = 0.31), though point estimates suggested that nurses and allied health professionals may have higher prevalence than other groups. These nonsignificant trends warrant further investigation in adequately powered primary studies. The findings illustrate the complexity of LTBI screening in a multinational workforce and underscore the importance of developing context-specific infection control policies.

The observed pooled prevalence of 24% among HCWs appears higher than the 9.8% prevalence reported in the general Saudi population [33]. Even when isolating Saudi national HCWs, our study found a pooled prevalence of 13%, which appears elevated compared to the general public. However, it should be noted that no formal statistical comparison was performed between these estimates, as they are derived from separate meta-analyses with different populations and methodologies. Nevertheless, the observed difference is suggestive of a possible occupational contribution to LTBI risk. Despite this limitation, when viewed through a global lens, the prevalence among HCWs in Saudi Arabia is comparatively moderate. Research studies of HCWs in low- and middle-income countries have reported prevalence rates as high as 49% [34], with similar rates (47%) observed in studies focusing on high-TB-burden nations [35]. The lower prevalence in Saudi Arabia reflects the country's declining TB incidence, which dropped from 10.55 per 100,000 in 2015-8.76 per 100,000 in 2019 [36]. The country achieved this relative success through strong infection control measures and implemented strict pre-employment screening policies for all workers.

The review shows that different national groups have different infection rates, which makes it difficult to compare against other countries that have low-incidence rates. Our analysis showed that HCWs from India and the Philippines had infection rates of 45% and 46%, respectively, which matched the rates in their home nations instead of the Saudi population average. This suggests that a significant portion of the HCWs’ LTBI in Saudi hospitals is imported rather than locally acquired. This finding aligns with other research which shows that TB epidemiological patterns among HCWs often follow the epidemiology of their foreign workforce instead of the local population [9,11,37].

The selection of diagnostic tests raised concerns about the specificity of the screening protocol, particularly for the bacille Calmette-Guérin (BCG)-vaccinated population. The TST-based studies reported a 27% pooled prevalence compared to 20% found in IGRA-based studies, although this difference did not reach statistical significance in the subgroup analysis. Similar findings were shown in another study, where they reported a 10% absolute difference between the TST and IGRA estimates [34]. The most prominent pattern of this difference was TST-positive/IGRA-negative. This is most likely attributed to the previous BCG vaccine and nontuberculous mycobacteria infection. In a review article by Nienhaus et al., they reported that BCG vaccination and migration background status together accounted for 85% of cases of this pattern [38]. Given that many expatriate HCWs in Saudi Arabia originate from countries with universal BCG vaccination policies, TST likely overestimates the true burden of LTBI in this setting. The occurrence of TST-negative/IGRA-positive discordance represents a rare situation that could lead to a missed diagnosis. This pattern might occur because of cutaneous anergy, immunosuppression, or in older populations. Gao et al., show that IGRA tests are more sensitive, particularly for this particular population, and more specific, which decreases the chances of overdiagnosis [39]. Moreover, while dual-testing strategies (IGRA confirmatory testing for individuals with positive TST results) have been explored, the authors found that the positive predictive value of IGRA alone was comparable to dual-testing strategies [39]. Given the observed discordance patterns and the well-documented limitations of TST in BCG-vaccinated populations, the scientific basis for using TST as the main screening method in a workforce with multiple nationalities and high vaccination rates is questionable, lending support to considering IGRA-based screening protocols.

The analysis of occupational categories revealed that allied health professionals (24%) and nurses (21%) had numerically higher prevalence than pharmacists (6%) and medical students (2%); however, these differences did not reach statistical significance (P = 0.31). While external literature has reported that frontline HCWs encounter greater exposure risk [34,35,40], the present analysis was unable to confirm this pattern statistically, likely due to limited subgroup sample sizes and high between-study heterogeneity. Other risk factors reported in the included studies were older age [[24], [25], [26], [27],[29], [30], [31], [32]], longer duration of employment [25,29,32], and working in high-risk areas like intensive care units or emergency departments [29,30,32].

The strengths of this review include its comprehensive search strategy and focus on a specific national context; however, some limitations must be acknowledged. First, a high degree of heterogeneity (I² = 98.8%) was observed across the included studies. This is a well-recognized characteristic of prevalence meta-analyses, where estimates are inherently influenced by differences in population demographics, geographic context, healthcare settings, and diagnostic methodology. As recommended by Borges Migliavaca et al., the purpose of pooling in this context is not to produce a single definitive estimate but rather to provide a summary measure while systematically exploring sources of heterogeneity through subgroup and sensitivity analyses, which we have performed [41].Second, the cross-sectional design of the included studies prevents the assessment of LTBI conversion rates or progression to active TB. Third, we were unable to fully adjust for the BCG status of participants in the TST subgroup analysis due to inconsistent reporting in primary studies. Fourth, none of the included studies reported using the two-step TST method, which establishes a true baseline by identifying boosted reactions in serially tested individuals. Without this approach, positive TST results from repeated occupational screening may include boosted responses misclassified as new infections, potentially inflating prevalence estimates, particularly in this heavily BCG-vaccinated population where periodic screening is routine. This may have further inflated TST-based prevalence estimates beyond the effect of BCG cross-reactivity alone.

The observed TST-positive/IGRA-negative discordance patterns, together with external evidence supporting IGRA's superior specificity in BCG-vaccinated populations [38,39], support consideration of transitioning to IGRA tests as the standard screening tool for HCWs. This could help decrease the requirement for unnecessary chest x-rays and chemoprophylaxis treatments for the high rate of individuals with TST-positive/IGRA-negative results, which will offer long-term cost reduction. Given that the majority of the detected LTBI burden appears to be imported, screening protocols should prioritize robust pre-employment baseline testing, particularly for expatriates arriving from high-TB-burden countries. For institutions where IGRA cannot be implemented, protocols should be risk-stratified, directing resources toward high-risk populations and those working in high-risk areas. Additionally, the presence of LTBI even among Saudi nationals (13%) suggests that some degree of local occupational transmission may be occurring, reminding us of the importance of continuing infection control measures, including rigorous fit-testing of N95 respirators and continuous education regarding the early recognition of TB symptoms.

In conclusion, while Saudi Arabia is a low-incidence country, HCWs appear to have a higher LTBI prevalence than the general population, although this comparison is indirect and was not formally tested for statistical significance. The evidence indicates that most of this burden is imported, with expatriate HCWs from high-TB-burden countries demonstrating prevalence rates that closely mirror the epidemiology of their countries of origin. Nevertheless, occupational exposure may also contribute, as suggested by the numerically higher prevalence observed among Saudi national HCWs compared to the reported general population estimate. Addressing this dual challenge requires robust pre-employment and periodic LTBI screening, particularly targeting expatriates from endemic regions, alongside continued strict adherence to infection control measures to minimize local occupational transmission.

CRediT authorship contribution statement

Mohammed Aljabr: Conceptualization, Data curation, Investigation, Methodology, Writing – original draft. Fatima N. Boumarah: Data curation, Investigation, Methodology, Writing – original draft. Yara Mortada: Data curation, Investigation, Writing – original draft. Ghala Alhmidani: Data curation, Investigation, Writing – original draft. Rakan Almutairi: Data curation, Investigation, Writing – original draft. Jory Msood: Data curation, Investigation, Writing – original draft. Noor Alfaraj: Data curation, Investigation, Writing – original draft. Shatha Abohimed: Data curation, Investigation, Writing – original draft. Adel Almaghrbi: Data curation, Investigation, Writing – original draft. Reham Algethami: Data curation, Investigation, Writing – original draft. Refal Alsaedi: Data curation, Investigation, Writing – original draft. Sadeem Al Maqeet: Data curation, Investigation, Writing – original draft. Abdullah Aljorayid: Conceptualization, Methodology, Project administration, Supervision, Validation, Writing – review & editing.

Declaration of competing interest

The authors have no competing interests to declare.

Acknowledgments

Funding

This research did not received any specific grant from any funding agencies in the public, commercial, or not-for-profit sectors.

Ethical approval

Not applicable. As this study involved the synthesis of previously published aggregate data, institutional review board approval was not required.

Declaration of generative AI and AI-assisted technologies in the manuscript preparation process

During the preparation of this work, the authors used Gemini (Google) in order to improve the language, clarity, and formatting of the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.

Footnotes

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.ijregi.2026.101000.

Appendix. Supplementary materials

mmc1.docx (5.8MB, docx)

References

  • 1.1st ed. World Health Organization; Geneva: 2024. Global Tuberculosis Report. [Google Scholar]
  • 2.Bai W., Ameyaw E.K. Global, regional and national trends in tuberculosis incidence and main risk factors: a study using data from 2000 to 2021. BMC Public Health. 2024;24:12. doi: 10.1186/s12889-023-17495-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Menzies N.A., Wolf E., Connors D., Bellerose M., Sbarra A.N., Cohen T., et al. Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. Lancet Infect Dis. 2018;18:e228–e238. doi: 10.1016/S1473-3099(18)30134-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Narasimhan P., Wood J., MacIntyre C.R., Mathai D. Risk factors for tuberculosis. Pulm Med. 2013;2013 doi: 10.1155/2013/828939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Emery J.C., Richards A.S., Dale K.D., McQuaid C.F., White R.G., Denholm J.T., et al. Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease. Proc Biol Sci. 2021;288 doi: 10.1098/rspb.2020.1635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Houben RMGJ, Dodd P.J. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLOS Med. 2016;13 doi: 10.1371/journal.pmed.1002152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pai M., Behr M.A., Dowdy D., Dheda K., Divangahi M., Boehme C.C., et al. Tuberculosis. Nat Rev Dis Primers. 2016;2 doi: 10.1038/nrdp.2016.76. [DOI] [PubMed] [Google Scholar]
  • 8.Baussano I., Nunn P., Williams B., Pivetta E., Bugiani M., Scano F. Tuberculosis among health care workers. Emerg Infect Dis. 2011;17:488–494. doi: 10.3201/eid1703.100947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mathema B., Andrews J.R., Cohen T., Borgdorff M.W., Behr M., Glynn J.R., et al. Drivers of tuberculosis transmission. J Infect Dis. 2017;216(Suppl. 6):S644–S653. doi: 10.1093/infdis/jix354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Uden L., Barber E., Ford N., Cooke G.S. Risk of tuberculosis infection and disease for health care workers: an updated meta-analysis. Open Forum Infect Dis. 2017;4:ofx137. doi: 10.1093/ofid/ofx137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Peters C., Kozak A., Nienhaus A., Schablon A. Risk of occupational latent tuberculosis infection among health personnel measured by interferon-gamma release assays in low incidence countries—a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;17:581. doi: 10.3390/ijerph17020581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Barry M. TB incidence trends in the Kingdom of Saudi Arabia within the GCC, EMR, and MENA regions, to achieve the WHO and UN’s SDG end TB strategy targets. J Epidemiol Glob Health. 2025;15:96. doi: 10.1007/s44197-025-00442-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Abdelwahab S.I., Taha M.M.E., Albasheer O., Alharbi A., Ahmed A.A., Abdelmola A., et al. Tuberculosis research advances and future trends: a bibliometric knowledge mapping approach. Medicine. 2024;103 doi: 10.1097/MD.0000000000039052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Abubakar I., Gautret P., Brunette G.W., Blumberg L., Johnson D., Poumerol G., et al. Global perspectives for prevention of infectious diseases associated with mass gatherings. Lancet Infect Dis. 2012;12:66–74. doi: 10.1016/S1473-3099(11)70246-8. [DOI] [PubMed] [Google Scholar]
  • 15.Hoang V-T, Gautret P. Infectious diseases and mass gatherings. Curr Infect Dis Rep. 2018;20:44. doi: 10.1007/s11908-018-0650-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Munn Z., Moola S., Lisy K., Riitano D., Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid-Based Healthc. 2015;13:147–153. doi: 10.1097/XEB.0000000000000054. [DOI] [PubMed] [Google Scholar]
  • 18.Ouzzani M., Hammady H., Fedorowicz Z., Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. doi: 10.1186/s13643-016-0384-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Downes M.J., Brennan M.L., Williams H.C., Dean R.S. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) BMJ Open. 2016;6 doi: 10.1136/bmjopen-2016-011458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chapter 10. Analysing data and undertaking meta-analyses. Cochrane, https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-10; [accessed 20 December 2025].
  • 21.West S.L., Gartlehner G., Mansfield A.J., Poole C., Tant E., Lenfestey N., et al. Agency for Healthcare Research and Quality (US); Rockville (MD): 2010. Comparative effectiveness review methods: clinical heterogeneity. Report No.: 10-EHC070-EF. PMID: 21433337. [PubMed] [Google Scholar]
  • 22.Chan B.K.C. Data analysis using R programming. Adv Exp Med Biol. 2018;1082:47–122. doi: 10.1007/978-3-319-93791-5_2. [DOI] [PubMed] [Google Scholar]
  • 23.Koshak E.A., Tawfeeq R.Z. Tuberculin reactivity among health care workers at King Abdulaziz University Hospital, Saudi Arabia. East Mediterr Health J. 2003;9:1034–1041. doi: 10.26719/2003.9.5-6.1034. [DOI] [PubMed] [Google Scholar]
  • 24.Abbas M.A.F., AlHamdan N.A., AlEnezy A.K., AlQahtani M.S. Prevalence of latent TB among health care workers in four Major Tertiary Care Hospitals in Riyadh. Saudi Arabia. J Egypt Public Health Assoc. 2010;85:61–71. PMID: 21073848. [PubMed] [Google Scholar]
  • 25.Hassan M.I., Diab A.E. Detection of latent tuberculosis infection among laboratory personnel at a University Hospital in Eastern Saudi Arabia using an interferon gamma release assay. J Infect Public Health. 2014;7:289–295. doi: 10.1016/j.jiph.2013.10.002. [DOI] [PubMed] [Google Scholar]
  • 26.El-Helaly M., Khan W., El-Saed A., Balkhy H.H. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia. J Infect Public Health. 2014;7:481–488. doi: 10.1016/j.jiph.2014.07.012. [DOI] [PubMed] [Google Scholar]
  • 27.Hibah N.A.A., Hasan H-EA. Prevalence of latent tuberculosis infection among multinational healthcare workers in Muhayil Saudi Arabia. Egypt J Bronchol. 2015;9:183–187. doi: 10.4103/1687-8426.158078. [DOI] [Google Scholar]
  • 28.Al Hajoj S., Varghese B., Datijan A., Shoukri M., Alzahrani A., Alkhenizan A., et al. Interferon gamma Release Assay versus Tuberculin Skin Testing among Healthcare Workers of Highly Diverse Origin in a Moderate tuberculosis Burden Country. PLOS One. 2016;11 doi: 10.1371/journal.pone.0154803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bukhary Z.A., Amer S.M., Emara M.M., Abdalla M.E., Ali S.A. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test. Ann Saudi Med. 2018;38:90–96. doi: 10.5144/0256-4947.2018.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Almohaya A., Aldrees A., Akkielah L., Hashim A.T., Almajid F., Binmoammar T., et al. Latent tuberculosis infection among health-care workers using QuantiFERON-TB gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors. Ann Saudi Med. 2020;40:191–199. doi: 10.5144/0256-4947.2020.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Alshahrani N.S., Kayal M., Alahmad Almshhad H., Dirar Q., AlKattan W., Shibl A., et al. The risk of latent tuberculosis infection among healthcare workers at a General Hospital in Bisha, the Kingdom of Saudi Arabia. Cureus. 2023;15 doi: 10.7759/cureus.40561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Aldhawyan N.M., Alkhalifah A.K., Kofi M., Yousef Y.M., Alqahtani A.A. Prevalence of latent tuberculosis infection among nurses working in critical areas at a Tertiary Care Hospital in Riyadh, Saudi Arabia. Cureus. 2024;16 doi: 10.7759/cureus.53389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Said B., Mohamed A.H., Eltyeb E., Eltayeb R., Abdalghani N., Siddig B., et al. The prevalence of Mycobacterium tuberculosis infection in Saudi Arabia: a systematic review and meta-analysis. J Epidemiol Glob Health. 2024;14:658–676. doi: 10.1007/s44197-024-00274-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Apriani L., McAllister S., Sharples K., Alisjahbana B., Ruslami R., Hill P.C., et al. Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review. Eur Respir J. 2019;53 doi: 10.1183/13993003.01789-2018. [DOI] [PubMed] [Google Scholar]
  • 35.Nasreen S., Shokoohi M., Malvankar-Mehta M.S. Prevalence of latent tuberculosis among health care workers in high burden countries: a systematic review and meta-analysis. PLoS One. 2016;11 doi: 10.1371/journal.pone.0164034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Alawi M.M., Alserehi H.A., Ali A.O., Albalawi A.M., Alanizi M.K., Nabet F.M., et al. Epidemiology of tuberculosis in Saudi Arabia following the implementation of end tuberculosis strategy: analysis of the surveillance data 2015–2019. Saudi Med J. 2024;45:60–68. doi: 10.15537/smj.2024.45.1.20230424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Shrivastava S.R., Bobhate P.S., Petkar P.B., Mendhe H.G., Bandre G.R. Strengthening tuberculosis control among migrant workers. Tropmed Infect Dis. 2024;9:274. doi: 10.3390/tropicalmed9110274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Nienhaus A., Schablon A., Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection – analysis of discordant results, when compared to the tuberculin skin test. PLOS One. 2008;3 doi: 10.1371/journal.pone.0002665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gao Q-H, Chen H-B, Huang Y., Cai S-L, Chen L-P, Yi Y-N, et al. Predictive value of interferon-gamma release assays and tuberculin skin test for latent tuberculosis infection: a systematic review and meta-analysis of head-to-head comparative tests. J Microbiol Immunol Infect. 2025;59:438–443. doi: 10.1016/j.jmii.2025.11.003. [DOI] [PubMed] [Google Scholar]
  • 40.Rafiza S., Rampal K.G., Tahir A. Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia. BMC Infect Dis. 2011;11:19. doi: 10.1186/1471-2334-11-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Migliavaca B.C., Stein C., Colpani V., Barker T.H., Munn Z., Falavigna M., et al. How are systematic reviews of prevalence conducted? A methodological study. BMC Med Res Methodol. 2020;20:96. doi: 10.1186/s12874-020-00975-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

mmc1.docx (5.8MB, docx)

Articles from IJID Regions are provided here courtesy of Elsevier

RESOURCES